The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age

BACKGROUND: Fluticasone propionate 50 μg/salmeterol xinafoate 25 μg (FP/SAL) is widely used in adults and children with asthma, but there is sparse information on its use in very young children. METHODS: This was a randomized, double‐blind, multicentre, controlled trial conducted in children aged 8 ...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshihara, Shigemi, Tsubaki, Toshikazu, Ikeda, Masanori, Lenney, Warren, Tomiak, Richard, Hattori, Takako, Hashimoto, Kenichi, Soutome, Toru, Kato, Shihona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850202/
https://www.ncbi.nlm.nih.gov/pubmed/30556939
http://dx.doi.org/10.1111/pai.13010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850202/
https://www.ncbi.nlm.nih.gov/pubmed/30556939
http://dx.doi.org/10.1111/pai.13010

Ejemplares similares